Suppr超能文献

醌类作为新型PIM1激酶抑制剂的鉴定。

Identification of quinones as novel PIM1 kinase inhibitors.

作者信息

Schroeder Richard L, Goyal Navneet, Bratton Melyssa, Townley Ian, Pham Nancy A, Tram Phan, Stone Treasure, Geathers Jasmine, Nguyen Kathy, Sridhar Jayalakshmi

机构信息

Department of Chemistry, Xavier University of Louisiana, 1, Drexel Dr., New Orleans, LA 70125, USA.

Cell and Molecular Biology Core Facility, Xavier University of Louisiana, New Orleans, LA 70125, USA.

出版信息

Bioorg Med Chem Lett. 2016 Jul 1;26(13):3187-3191. doi: 10.1016/j.bmcl.2016.04.079. Epub 2016 Apr 28.

Abstract

PIM1 is a proto-oncogene encoding the serine/threonine PIM1 kinase. PIM1 kinase plays important roles in regulating aspects of cell cycle progression, apoptosis resistance, and has been implicated in the development of such malignancies as prostate cancer and acute myeloid leukemia among others. Knockout of PIM1 kinase in mice has been shown to be non-lethal without any obvious phenotypic changes, making it an attractive therapeutic target. Our investigation of anthraquinones as kinase inhibitors revealed a series of quinone analogs showing high selectivity for inhibition of the PIM kinases. Molecular modeling studies were used to identify key interactions and binding poses of these compounds within the PIM1 binding pocket. Compounds 1, 4, 7 and 9 inhibited the growth of DU-145 prostate cancer cell lines with a potency of 8.21μM, 4.06μM, 3.21μM and 2.02μM.

摘要

PIM1是一种原癌基因,编码丝氨酸/苏氨酸PIM1激酶。PIM1激酶在调节细胞周期进程、抗凋亡等方面发挥重要作用,并且与前列腺癌和急性髓系白血病等恶性肿瘤的发生有关。已证明敲除小鼠体内的PIM1激酶不会致死,也不会产生任何明显的表型变化,这使其成为一个有吸引力的治疗靶点。我们对蒽醌类作为激酶抑制剂的研究发现了一系列对PIM激酶抑制具有高选择性的醌类似物。分子建模研究用于确定这些化合物在PIM1结合口袋内的关键相互作用和结合构象。化合物1、4、7和9对DU - 145前列腺癌细胞系生长的抑制效力分别为8.21μM、4.06μM、3.21μM和2.02μM。

相似文献

1
Identification of quinones as novel PIM1 kinase inhibitors.
Bioorg Med Chem Lett. 2016 Jul 1;26(13):3187-3191. doi: 10.1016/j.bmcl.2016.04.079. Epub 2016 Apr 28.
2
Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors.
Bioorg Med Chem. 2016 Apr 15;24(8):1889-97. doi: 10.1016/j.bmc.2016.03.016. Epub 2016 Mar 7.
3
Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors.
Bioorg Med Chem Lett. 2018 Aug 1;28(14):2513-2517. doi: 10.1016/j.bmcl.2018.05.054. Epub 2018 May 29.
4
Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2424-8. doi: 10.1016/j.bmcl.2014.04.035. Epub 2014 Apr 16.
5
Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
Expert Opin Ther Pat. 2014 Jan;24(1):5-17. doi: 10.1517/13543776.2014.848196. Epub 2013 Oct 17.
6
Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
Eur J Med Chem. 2012 Oct;56:225-36. doi: 10.1016/j.ejmech.2012.08.029. Epub 2012 Aug 30.
7
2-Thioxothiazolidin-4-one Analogs as Pan-PIM Kinase Inhibitors.
Chem Pharm Bull (Tokyo). 2021;69(9):854-861. doi: 10.1248/cpb.c21-00264.
9
Discovery of N-substituted 7-azaindoles as PIM1 kinase inhibitors - Part I.
Bioorg Med Chem Lett. 2017 Oct 15;27(20):4730-4734. doi: 10.1016/j.bmcl.2017.08.069. Epub 2017 Sep 18.
10
Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.
Bioorg Med Chem Lett. 2010 May 1;20(9):2801-5. doi: 10.1016/j.bmcl.2010.03.061. Epub 2010 Mar 15.

引用本文的文献

1
Crystal structure of 4-bromo-5,7-dimeth-oxy-2,3-di-hydro-1-inden-1-one.
Acta Crystallogr E Crystallogr Commun. 2024 Jul 19;80(Pt 8):873-877. doi: 10.1107/S2056989024006522. eCollection 2024 Aug 1.
2
Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of GSK-3.
Biomedicines. 2022 May 14;10(5):1136. doi: 10.3390/biomedicines10051136.
3
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.
Med Oncol. 2022 May 15;39(5):74. doi: 10.1007/s12032-022-01675-2.
5
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y.
6
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials.
Sci Transl Med. 2019 Sep 11;11(509). doi: 10.1126/scitranslmed.aaw8412.

本文引用的文献

1
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.
Bioorg Med Chem Lett. 2011 May 15;21(10):3050-6. doi: 10.1016/j.bmcl.2011.03.030. Epub 2011 Mar 16.
2
A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Acta Crystallogr D Biol Crystallogr. 2011 Mar;67(Pt 3):156-66. doi: 10.1107/S0907444910054144. Epub 2011 Feb 15.
3
Why target PIM1 for cancer diagnosis and treatment?
Future Oncol. 2010 Sep;6(9):1461-78. doi: 10.2217/fon.10.106.
6
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
Biochem J. 2009 Jul 15;421(3):387-95. doi: 10.1042/BJ20090069.
9
Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.
J Med Chem. 2009 Jan 8;52(1):74-86. doi: 10.1021/jm800937p.
10
Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.
J Med Chem. 2008 Mar 27;51(6):1972-5. doi: 10.1021/jm701248t. Epub 2008 Feb 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验